Novavax, Inc. - Common Stock (NQ:NVAX)

12.56 +2.10 (+20.08%)

Delayed Quote Updated: 4:00 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Novavax, Inc. - Common Stock

< Previous 1 2

...

28 29 30 31 32 33 34 35 36

...

68 69 Next >

Stocks That Hit 52-Week Lows On Wednesday ↗

September 07, 2022

On Wednesday, 297 companies achieved new lows for the year.

Via Benzinga

Recap Of Friday's Biotech Catalysts - End Of the Day Summary ↗

September 02, 2022

Via Benzinga

Recap Of Thursday's Biotech Catalysts - End Of the Day Summary ↗

September 01, 2022

Via Benzinga

What Is Going on With Vaxart (VXRT) Stock Today? ↗

September 01, 2022

Vaxart released encouraging results for its oral Covid-19 vaccine, though sentiment for VXRT stock presently remains mixed.

Via InvestorPlace

Europe Backs Approval Of Omicron-Adapted COVID-19 Vaccines ↗

September 01, 2022

Health Canada has approved Moderna Inc's (NASDAQ:

Via Benzinga

Top Financial Stories Thursday, September 1: Netflix Weighs Charging High Sum For Ads, Self Harm posts Grow On Twitter, California Fast-Food Bill Faces Industry Backlash... ↗

September 01, 2022

Wall Street Journal

Via Benzinga

Novavax Scores Another Nod For Its COVID-19 Shot In Adolescents ↗

August 26, 2022

Via Benzinga

HP, Ambarella, Bed Bath & Beyond And Other Big Losers From Wednesday ↗

September 01, 2022

U.S. stocks closed lower with the Dow Jones dropping around 280 points on Wednesday. Here is the list of some big stocks moving lower in the previous session.

Via Benzinga

Why Is Novavax (NVAX) Stock Down Today? ↗

August 31, 2022

Pfizer and Moderna received FDA approval for their omicron-specific booster. NVAX stock is hitting new 52-week lows in response.

Via InvestorPlace

Why Novavax Shares Are Getting Hammered After Moderna, Pfizer And BioNTech News ↗

August 31, 2022

Novavax, Inc. (NASDAQ: NVAX) shares are trading lower by 6.76% to $32.84 Wednesday afternoon in possible reaction to competitor Moderna Inc (NASDAQ: MRNA) receiving FDA authorization for emergency use...

Via Benzinga

Recap Of Friday's Biotech Catalysts - End Of the Day Summary ↗

August 26, 2022

Via Benzinga

FDA Approves Novavax's COVID-19 Vaccine For Use In Adolescents ↗

August 22, 2022

Via Benzinga

Novavax Seeks FDA Emergency Use Nod For Its COVID-19 Vaccine Booster ↗

August 15, 2022

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

August 26, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Novavax Obtains U.K. Regulatory Clearance For Nuvaxovid In Adolescents Aged 12-17 Years ↗

August 26, 2022

The Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom (UK) has granted expanded conditional marketing authorization (CMA) for Novavax’s (NASDAQ: NVAX) lead asset...

Via Benzinga

Pfizer And Moderna Are In A Race With Omicron; Will The Vaccine Stocks Be Too Late? ↗

August 26, 2022

The companies hope to launch updated boosters this fall. This is what experts think of their prospects.

Via Investor's Business Daily

Face Of US COVID-19 Response, Dr Anthony Fauci To Retire In December ↗

August 22, 2022

Via Benzinga

Covid Stocks Pfizer, Moderna, Novavax Face Their Next Challenge, And It's Worth Billions ↗

August 19, 2022

How they handle an upcoming shift in payments will be telling for their tailwind.

Via Investor's Business Daily

Novavax's Covid-19 Vaccine Cleared For Use In New Zealanders Aged 12-17 ↗

August 18, 2022

Via Benzinga

This Healthcare Stock Dipped Over 30%; Here Are 83 Biggest Movers From Yesterday ↗

August 18, 2022

Gainers

Via Benzinga

If You Invested $1,000 In Johnson & Johnson Stock At Its COVID-19 Pandemic Low, Here's How Much You'd Have Now ↗

August 17, 2022

Investors who bought stocks during the COVID-19 market crash in 2020 have generally experienced some big gains in the past two years. But there is no question some big-name stocks performed better than...

Via Benzinga

Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary ↗

August 17, 2022

Via Benzinga

Biden Administration To Stop Purchasing COVID-19 Solutions By End Of 2022 ↗

August 17, 2022

Via Benzinga

Sanofi, Children's Place And Some Other Big Stocks Moving Lower On Wednesday ↗

August 17, 2022

Embark Technology, Inc. (NASDAQ: EMBK) fell 25.1% to $12.40. Embark Technology reported the completion of reverse stock split.

Via Benzinga

Why Blue Water Vaccines Is Trading Higher By Around 80%, Here Are 61 Stocks Moving In Wednesday's Mid-Day Session ↗

August 17, 2022

Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 79.5% to $4.57 after the company announced it plans to explore the potential development of a novel monkeypox vaccine using its norovirus...

Via Benzinga

Here's How Much You Would Have Made Owning Novavax Stock In The Last 5 Years ↗

August 17, 2022

Novavax (NASDAQ:NVAX) has outperformed the market over the past 5 years by 3.21% on an annualized basis producing an average annual return of 14.91%. Currently, Novavax has a market capitalization of...

Via Benzinga

Recap Of Monday's Biotech Catalysts - End Of the Day Summary ↗

August 15, 2022

Via Benzinga

Recap Of Friday's Biotech Catalysts - End Of the Day Summary ↗

August 12, 2022

Via Benzinga

Here's Why Novavax Shares Are Trading Higher ↗

August 12, 2022

Novavax, Inc. (NASDAQ: NVAX) shares are trading higher by 2.80% to $41.47, though off the session high of $43.06 after the company announced its Novaxovid COVID-19 vaccine has been approved in South...

Via Benzinga

Stock Market Rally Rises On Inflation Data; Nvidia, Micron, Tesla, Disney In Focus: Weekly Review ↗

August 12, 2022

The major indexes continued to advance, despite some key warnings.

Via Investor's Business Daily

< Previous 1 2

...

28 29 30 31 32 33 34 35 36

...

68 69 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.